![Paul A. Barsanti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul A. Barsanti
Technik-/Wissenschafts-/F&E-Leiter bei
IDEAYA BIOSCIENCES, INC.
Profil
Paul A. Barsanti is Chief Technology Officer at IDEAYA Biosciences, Inc. since 2023.
Formerly, Dr. Barsanti was Head-Chemistry at Nurix Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree conferred in 1993 and a doctorate conferred in 1996, both from the University of Bath.
Aktive Positionen von Paul A. Barsanti
| Unternehmen | Position | Beginn |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2023 |
Ehemalige bekannte Positionen von Paul A. Barsanti
| Unternehmen | Position | Ende |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2018 |
Ausbildung von Paul A. Barsanti
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
